Cancer Clinical Trial
Official title:
Reiki Therapy - an Intervention in Hematology/Oncology Cancer Patients Hospitalized in an Inpatient Setting - a Pilot Study.
NCT number | NCT03946865 |
Other study ID # | 19-000456 |
Secondary ID | |
Status | Withdrawn |
Phase | N/A |
First received | |
Last updated | |
Start date | July 10, 2019 |
Est. completion date | April 1, 2021 |
Verified date | April 2021 |
Source | Mayo Clinic |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Researchers are trying to determine if offering and providing reiki therapy in hospitalized hematology/oncology cancer subjects has any effects on symptoms and feeling during the subjects hospital stay.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | April 1, 2021 |
Est. primary completion date | April 1, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - Hospitalized hematology-oncology patients age 18 - 80 - Able to speak English and complete surveys - Able to read, understand and sign inform consent. Exclusion Criteria: - Patient unwilling for reiki therapy. - Unable to give written consent. - Already having received or receiving other reiki treatment. - Pregnant women. (As verbalized by participant) |
Country | Name | City | State |
---|---|---|---|
United States | Mayo Clinic in Rochester | Rochester | Minnesota |
Lead Sponsor | Collaborator |
---|---|
Mayo Clinic |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in pain pain symptoms | Measured using a numeric rating scale, where 0 is not at all and 10 is unbearable | Baseline, approximately 2 hours | |
Primary | Change in fatigue symptoms | Measured using a numeric rating scale, where 0 is not at all and 10 is unbearable | Baseline, approximately 2 hours | |
Primary | Change in anxiety symptoms | Measured using a numeric rating scale, where 0 is not at all and 10 is unbearable | Baseline, approximately 2 hours | |
Primary | Change in feeling happy | Measured using a numeric rating scale, where 0 is best possible and 10 is worst possible | Baseline, approximately 2 hours | |
Primary | Change in feeling energized | Measured using a numeric rating scale, where 0 is best possible and 10 is worst possible | Baseline, approximately 2 hours | |
Primary | Change in feeling relaxed | Measured using a numeric rating scale, where 0 is best possible and 10 is worst possible | Baseline, approximately 2 hours | |
Primary | Change in feeling calm | Measured using a numeric rating scale, where 0 is best possible and 10 is worst possible | Baseline, approximately 2 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|